9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      LncRNA DCST1-AS1 Sponges miR-107 to Upregulate CDK6 in Cervical Squamous Cell Carcinoma

      research-article
      1 , 1
      Cancer Management and Research
      Dove
      DCST1-AS1, miR-107, cervical squamous cell carcinoma, CSCC, CDK6, proliferation

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          LncRNAs have been reported to play critical roles in liver cancer, while its role in other cancers remains unclear. The aim of this study was to investigate the role of DCST1-AS1 in cervical squamous cell carcinoma (CSCC).

          Methods

          Expression of DCST1-AS1 in CSCC tissues and non-tumor tissues from 68 CSCC patients was determined by RT-qPCR. A 5-year follow-up study was carried out to explore the prognostic value of DCST1-AS1 for CSCC. Overexpression of DCST1-AS1 and miR-107 was achieved in CSCC tissues to explore the interaction between them. The roles of DCST1-AS1, miR-107 and CDK6 in regulating the proliferation and viability of CSCC cells were assessed by cell proliferation and viability assays, respectively.

          Results

          We found that DCST1-AS1 was upregulated in CSCC and predicted poor survival. RNA interaction prediction showed potential interaction between DCST1-AS1 and miR-107. However, overexpression experiments revealed no significant interaction between them. Moreover, overexpression of DCST1-AS1 led to upregulate CDK6 and increase cell proliferation rate, while overexpression of miR-107 played an opposite role and attenuate the effects of overexpression of DCST1-AS1.

          Conclusion

          DCST1-AS1 may sponge miR-107 to upregulate CDK6 in CSCC.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Cell cycle proteins as promising targets in cancer therapy

          Cancer is characterized by uncontrolled tumour cell proliferation resulting from aberrant activity of various cell cycle proteins. Therefore, cell cycle regulators are considered attractive targets in cancer therapy. Intriguingly, animal models demonstrate that some of these proteins are not essential for proliferation of non-transformed cells
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Targeting CDK4 and CDK6: From Discovery to Therapy.

            Biochemical and genetic characterization of D-type cyclins, their cyclin D-dependent kinases (CDK4 and CDK6), and the polypeptide CDK4/6 inhibitor p16(INK4)over two decades ago revealed how mammalian cells regulate entry into the DNA synthetic (S) phase of the cell-division cycle in a retinoblastoma protein-dependent manner. These investigations provided proof-of-principle that CDK4/6 inhibitors, particularly when combined with coinhibition of allied mitogen-dependent signal transduction pathways, might prove valuable in cancer therapy. FDA approval of the CDK4/6 inhibitor palbociclib used with the aromatase inhibitor letrozole for breast cancer treatment highlights long-sought success. The newest findings herald clinical trials targeting other cancers.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.

              Using highly sensitive polymerase chain reaction (PCR) techniques, we reanalysed all cervical carcinomas (CCs) found to be human papillomavirus (HPV)-negative by Hybrid Capture 2 (HC2) to determine the prevalence of true HPV-negativity. We also evaluated the characteristics of the patients with tumours with confirmed HPV-negativity.
                Bookmark

                Author and article information

                Journal
                Cancer Manag Res
                Cancer Manag Res
                cmar
                cancmanres
                Cancer Management and Research
                Dove
                1179-1322
                28 August 2020
                2020
                : 12
                : 7921-7928
                Affiliations
                [1 ]Department of Gynecological Oncology, Maternal and Child Health Hospital of Hubei Province , Wuhan City, Hubei Province, People’s Republic of China
                Author notes
                Correspondence: Na Xia Tel +86 15902772665 Email naxia301@aliyun.com
                Article
                251582
                10.2147/CMAR.S251582
                7468448
                32943926
                2550333a-1f25-4bab-bc78-c61c7edd59c6
                © 2020 Zhou and Xia.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 27 February 2020
                : 10 July 2020
                Page count
                Figures: 6, References: 17, Pages: 8
                Categories
                Original Research

                Oncology & Radiotherapy
                dcst1-as1,mir-107,cervical squamous cell carcinoma,cscc,cdk6,proliferation
                Oncology & Radiotherapy
                dcst1-as1, mir-107, cervical squamous cell carcinoma, cscc, cdk6, proliferation

                Comments

                Comment on this article